Liquidia Corp Files 2024 Annual Report

Ticker: LQDA · Form: 10-K · Filed: Mar 19, 2025

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Liquidia Corp's 2024 10-K is in: check financials, biz ops, and future outlook.

AI Summary

Liquidia Corporation filed its 10-K for the fiscal year ending December 31, 2024, reporting its financial performance and business operations. The company, incorporated in Delaware, is based in Morrisville, NC, and operates in the pharmaceutical preparations sector. Key financial data and operational details for the period are outlined in the filing.

Why It Matters

This 10-K filing provides investors and stakeholders with a comprehensive overview of Liquidia Corp's financial health, strategic initiatives, and potential risks for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Liquidia faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What were Liquidia Corporation's total assets as of December 31, 2024?

Liquidia Corporation reported total assets of $84,683,063 as of December 31, 2024.

What were Liquidia Corporation's total liabilities as of December 31, 2024?

Liquidia Corporation reported total liabilities of $68,629,575 as of December 31, 2024.

What is Liquidia Corporation's Standard Industrial Classification (SIC) code?

Liquidia Corporation's SIC code is 2834, which corresponds to Pharmaceutical Preparations.

In which state was Liquidia Corporation incorporated?

Liquidia Corporation was incorporated in Delaware (DE).

What is the SEC file number for Liquidia Corporation?

The SEC file number for Liquidia Corporation is 001-39724.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 19, 2025 regarding Liquidia Corp (LQDA).

View full filing on EDGAR

View on Read The Filing